News & Updates

Voluntary CDSS for antibiotic stewardship does not compromise clinical outcomes

11 Aug 2020 by

Voluntary use of computerized decision support system (CDSS) for antibiotic stewardship did not compromise appropriate indication of antibiotics and clinical outcomes compared with compulsory implementation of CDSS, a local study has shown.

Voluntary CDSS for antibiotic stewardship does not compromise clinical outcomes

11 Aug 2020

Once-a-month prevention pill succeeds in malaria-endemic areas

11 Aug 2020 by

Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Once-a-month prevention pill succeeds in malaria-endemic areas

11 Aug 2020

Does physical distancing reduce the incidence of COVID-19?

11 Aug 2020 by

The implementation of physical distancing measures in response to the novel coronavirus disease (COVID-19) pandemic has been shown to be an effective strategy, resulting in a 13-percent decrease in the incidence of COVID-19 globally, according to a study.

Does physical distancing reduce the incidence of COVID-19?

11 Aug 2020

Tocilizumab may cut intubation, death rates in severe COVID-19 pneumonia patients

11 Aug 2020 by

Adding tocilizumab to standard-of-care* (SOC) may reduce the risk of invasive mechanical ventilation (MV) or death in patients with severe coronavirus 2019 (COVID-19) pneumonia, the TESEO** study has shown.

Tocilizumab may cut intubation, death rates in severe COVID-19 pneumonia patients

11 Aug 2020

COVID-19 may be linked to liver dysfunction, HBV reactivation

11 Aug 2020 by

Liver dysfunction may also be a manifestation of the coronavirus disease 2019 (COVID-19), according to a new study. In patients with chronic hepatitis B virus (HBV) infection, COVID-19 may also trigger reactivation of the virus.

COVID-19 may be linked to liver dysfunction, HBV reactivation

11 Aug 2020

Adjunctive daptomycin confers no benefit in MSSA bloodstream infections

11 Aug 2020

For patients with methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections, the use of daptomycin as an adjunct to standard treatment does not help shorten the duration of bacteraemia and, hence, should be done away with, as suggested in a study.

Adjunctive daptomycin confers no benefit in MSSA bloodstream infections

11 Aug 2020

Switching from EFV/FTC/TDF to BIC/FTC/TAF maintains virologic suppression in people living with HIV

11 Aug 2020 by

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

Switching from EFV/FTC/TDF to BIC/FTC/TAF maintains virologic suppression in people living with HIV

11 Aug 2020

Baloxavir effective as postexposure prophylaxis in household contacts of flu patients

10 Aug 2020 by

Postexposure prophylaxis with baloxavir marboxil reduced influenza incidence in household contacts of patients diagnosed with influenza, according to a study from Japan.

Baloxavir effective as postexposure prophylaxis in household contacts of flu patients

10 Aug 2020

Cabotegravir superior to TDF/FTC for HIV prevention

10 Aug 2020 by

Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.

Cabotegravir superior to TDF/FTC for HIV prevention

10 Aug 2020

Dolutegravir suppresses HIV in pregnant women without upping neural tube defect risk

10 Aug 2020 by

The benefit of using dolutegravir for HIV treatment in pregnant women outweighs the risk. This is the message delivered by two studies presented at the 23rd International AIDS Conference, which have shown that the drug induces rapid viral suppression and brings a slight but nonsignificant risk of neural tube defects (NTDs) compared with other antiretrovirals.

Dolutegravir suppresses HIV in pregnant women without upping neural tube defect risk

10 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Voluntary CDSS for antibiotic stewardship does not compromise clinical outcomes

Voluntary CDSS for antibiotic stewardship does not compromise clinical outcomes

Once-a-month prevention pill succeeds in malaria-endemic areas

Once-a-month prevention pill succeeds in malaria-endemic areas

Does physical distancing reduce the incidence of COVID-19?

Does physical distancing reduce the incidence of COVID-19?

Tocilizumab may cut intubation, death rates in severe COVID-19 pneumonia patients

Tocilizumab may cut intubation, death rates in severe COVID-19 pneumonia patients

COVID-19 may be linked to liver dysfunction, HBV reactivation

COVID-19 may be linked to liver dysfunction, HBV reactivation

Adjunctive daptomycin confers no benefit in MSSA bloodstream infections

Adjunctive daptomycin confers no benefit in MSSA bloodstream infections

Switching from EFV/FTC/TDF to BIC/FTC/TAF maintains virologic suppression in people living with HIV

Switching from EFV/FTC/TDF to BIC/FTC/TAF maintains virologic suppression in people living with HIV

Baloxavir effective as postexposure prophylaxis in household contacts of flu patients

Baloxavir effective as postexposure prophylaxis in household contacts of flu patients

Cabotegravir superior to TDF/FTC for HIV prevention

Cabotegravir superior to TDF/FTC for HIV prevention

Dolutegravir suppresses HIV in pregnant women without upping neural tube defect risk

Dolutegravir suppresses HIV in pregnant women without upping neural tube defect risk